I must be missing something here with OML, they had a NPAT for H1 2016 of $11.4m so to get to CY2016 NPAT of $38m H2 results would be $26.6m well over 100% growth in 6months? Is that correct or is it meant to be $28m?
APO Price at posting:
$4.87 Sentiment: Buy Disclosure: Held